KR930701183A - 칼슘 및 미량의 무기물 보충제 - Google Patents

칼슘 및 미량의 무기물 보충제

Info

Publication number
KR930701183A
KR930701183A KR1019930700348A KR930700348A KR930701183A KR 930701183 A KR930701183 A KR 930701183A KR 1019930700348 A KR1019930700348 A KR 1019930700348A KR 930700348 A KR930700348 A KR 930700348A KR 930701183 A KR930701183 A KR 930701183A
Authority
KR
South Korea
Prior art keywords
copper
manganese
citrate
zinc
calcium
Prior art date
Application number
KR1019930700348A
Other languages
English (en)
Other versions
KR0180207B1 (ko
Inventor
데이비드 솔트만 폴
토마스 스미스 켄네쓰
Original Assignee
제이코버스 코넬리스 레이서
더 프록터 앤드 갬블 캄파니
윌리엄 티. 아담스
더 리전츠 오브 더 유니버시티 오브 캘리포니아
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 제이코버스 코넬리스 레이서, 더 프록터 앤드 갬블 캄파니, 윌리엄 티. 아담스, 더 리전츠 오브 더 유니버시티 오브 캘리포니아 filed Critical 제이코버스 코넬리스 레이서
Publication of KR930701183A publication Critical patent/KR930701183A/ko
Application granted granted Critical
Publication of KR0180207B1 publication Critical patent/KR0180207B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/32—Manganese; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
  • Adornments (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)

Abstract

본 발명은 칼슘 시트레이트 말레이트와 망간, 구리 및 아연염을 포함하는 영양 무기물 보충제를 개시하고 있다. 무기물의 RDA 25% 이상을 제공하는 상기 보충제를 보편적인 음식과 함께 섭취한다. 상기 보충제는 인간 및 동물의 골의 성장을 증진시키고 노화로 인한 골 손상을 치료하는데 유용하다.

Description

칼슘 및 미량의 무기물 보충제
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (13)

175 내지 2000mg/1일의 양(칼슘원소를 기준으로)으로 투여되는 칼슘 시트레이트 말레이트, 1.5 내지 30㎎/1일의 양으로 투여되는 아연염, 1 내지 8㎎/일의 양으로 투여되는 망간염 및 1.0 내지 5..0㎎/1일의 양으로 투여되는 구리염을 포함한 무기물 보충제를 노화로 인한 골 손상을 받고 있는 대상 인체에게 골을 강화시키기에 충분한 기간, 바람직하게는 6달 이상동안 투여함을 포함하는, 상기 대상 인체에서 골을 강화시키기 위한 방법.
제1항에 있어서, 상기 무기물 고충제가 고형 투여용량형태인 방법.
제1항에 있어서, 상기 무기물 고충제가 고형 투여용량형태, 바람직하게는 음료형태인 방법.
제1항 내지 제3항중 어느 한 항에 있어서, 상기 칼슘 시트레인트 말레이트가 1:0.5 내지 1:4.5, 바람직하게는 1:0.75 내지 1:3의 시트레이트:말레이트의 몰비를 갖고, 상기 아연이 7.5 내지 20㎎이고, 상기 구리가 0.5 내지 5㎎이고, 상기 망간이2 내지 7㎎인 방법.
제1항 내지 제4항중 어느 한항에 있어서, 상기 구리, 망간 및 아연이 글루코네이트, 설페이트, 클로라이드, 시트레이트, 말레이트, 락테이트, 타르트레이트, 니트레이트 및 이들의 혼합물로 이루어진 군중에서 선택된 음이온 염형태인 방법.
제3항, 제4항 내지 제5항중 어느 한항에 있어서, 상기 음료가 과즙, 바람직하게는 오렌지즙, 사과즙, 배즙 및 크랜베리즙으로 이루어진 군중에서 선택된 과즙을 함유하는 방법.
제1항 내지 제6항중 어느 한항에 있어서, 상기 기간이 상기 대상인체의 골격 순량을 최소한 0.5%까지 증가시키기에 충분한 방법.
제1항, 제2항, 제4항 내지 제7항중 어느 한항에 있어서, 상기 무기물 보충제를 무슨 음료 혼합물에 가하는 방법.
a)시트레이트, 말레이트, 락테이트 및 이들의 혼합물로 이루어진 군중에서 선택된 카복실레이트 형태의 칼슘 100 내지 1000㎎(원소기준, 바람직하게는 시트레이트 말레이트 형태의 칼슘 100 내지 500㎎(여기에서, 칼슘:시트레이트:말레이트의 몰비는 2:1:1 내지 6:3:4이다), b)구리 0.5 내지 4㎎(원소 기준), c)아연 1.5 내지 30㎎(원소기준) 및 d) 망간 1 SOW 8㎎(원소기준)의 단위용량 혼합물을 포함하며, 바람직하게는 구리, 아연 및 망간이 염 형태로 아연 7.5 내지 20㎎, 구리 1 내지 3㎎ 및 망간 4 내지 6㎎의 개별적인 혼합물을 형성하는, 골을 강화시키기 위한 무기물 보충제.
제9항에 있어서, 상기 구리, 아연 및 망간이 클로라이드, 설페이트, 글루코네이트, 시트레이트, 말레이트, 락테이트, 타르트레이트, 니트레이트 및 이들의 혼합물로 이루어진 군중에서 선택된 음이온 염인 보충제.
제1항 내지 제7항중 어느 한 항에 있어서, 안전 유효량의 에스트로겐, 바람직하게는 0.6 내지 6㎎의 단위 용량의 에스트로겐을 대상인체에 또한 투여하는 방법.
대상인체의 골을 강화시키기 위한 제9항 또는 제10항의 무기물 보충제의 용도.
※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019930700348A 1990-08-06 1991-08-02 칼슘 및 미량의 무기물 보충제 KR0180207B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US562,773 1990-08-06
US07/562,773 US5151274A (en) 1990-08-06 1990-08-06 Calcium and trace mineral supplements
PCT/US1991/005496 WO1992002235A1 (en) 1990-08-06 1991-08-02 Calcium and trace mineral supplements

Publications (2)

Publication Number Publication Date
KR930701183A true KR930701183A (ko) 1993-06-11
KR0180207B1 KR0180207B1 (ko) 1999-03-20

Family

ID=24247717

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019930700348A KR0180207B1 (ko) 1990-08-06 1991-08-02 칼슘 및 미량의 무기물 보충제

Country Status (16)

Country Link
US (1) US5151274A (ko)
EP (1) EP0542912B1 (ko)
JP (1) JP3251287B2 (ko)
KR (1) KR0180207B1 (ko)
AT (1) ATE123223T1 (ko)
AU (1) AU662109B2 (ko)
CA (1) CA2088274C (ko)
DE (1) DE69110130T2 (ko)
HK (1) HK1006149A1 (ko)
IE (1) IE66702B1 (ko)
MX (1) MX9100556A (ko)
MY (1) MY107865A (ko)
NZ (1) NZ239264A (ko)
SA (1) SA92120558B1 (ko)
TW (1) TW201692B (ko)
WO (1) WO1992002235A1 (ko)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2102210C (en) * 1991-05-06 1998-08-04 Mark Benson Andon Combined calcium and vitamin d supplements
HUT66379A (en) * 1991-05-28 1994-11-28 Procter & Gamble Calcium, trace mineral, vitamin d and drug therapy combinations
US5397589A (en) * 1992-09-02 1995-03-14 Ohio State University Research Foundation Preparation of calcium fortified powdered milk products with improved dispersibility
IL115241A (en) * 1994-09-26 2000-08-31 American Cyanamid Co Calcium dietary supplement
GB2299992A (en) * 1995-04-20 1996-10-23 Willem Jacob Serfontein Complexes of magnesium and calcium
US6133317A (en) * 1995-11-15 2000-10-17 Hart; Francis J. Oxalic acid or oxalate composition and method of treatment
US6133318A (en) 1995-11-15 2000-10-17 Hart; Francis J. Oxalic acid or oxalate compositions and methods for bacterial, viral, and other diseases or conditions
DE19629167C2 (de) * 1996-07-19 2000-05-04 Einhorn Apotheke Dr Guenther H Feste orale, antikariogene Zusammensetzung in Form einer Lutschtablette zum Reinigen der Mundhöhle und Zähne
US20050245612A1 (en) * 2004-05-03 2005-11-03 Blass John P Pharmaceutical compositions for metabolic insufficiencies
US6811800B2 (en) * 1998-09-29 2004-11-02 The Procter & Gamble Co. Calcium fortified beverages
DE19957287C2 (de) * 1999-11-29 2002-10-31 Reinhard Bertram Verwendung einer homöopathischen Zubereitung zur Behandlung von Lockerungssymtomen bei alloarthroplastischen Implantaten
CA2395447A1 (en) 2000-01-28 2001-08-02 Robert Joseph Sarama Palatable arginine compounds and uses thereof for cardiovascular health
US6803064B1 (en) 2000-06-14 2004-10-12 Pepsico, Inc. Calcium fortified beverage compositions and process for preparing the same
AU2002211770A1 (en) 2000-10-16 2002-04-29 Pepsico, Inc. Calcium-supplemented beverages and method of making same
US6616955B2 (en) 2001-01-04 2003-09-09 The Proctor & Gamble Co. Beverage compositions comprising palatable calcium and magnesium sources
WO2002071857A1 (en) 2001-03-12 2002-09-19 Bristol-Myers Squibb Company Confectionery compositions containing fiber
US6632449B2 (en) 2001-11-20 2003-10-14 The Procter & Gamble Co. Compositions and kits comprising a defined boron compound and methods of their preparation
US7393552B2 (en) * 2002-04-24 2008-07-01 The Procter & Gamble Company Compositions comprising protein and fatty acid
US20030203042A1 (en) * 2002-04-24 2003-10-30 Cook Lisa Ann Compositions comprising milk protein concentrate and fatty acid and processes of their preparation
US20030203097A1 (en) * 2002-04-24 2003-10-30 The Procter & Gamble Company Acidic compositions comprising protein and fiber and processes of their preparation
US20030045473A1 (en) * 2002-07-19 2003-03-06 Sarama Robert Joseph Compositions, kits, and methods for cardiovascular health
US20040048925A1 (en) * 2002-09-09 2004-03-11 Wiley David B. Composition and method for enhancing the bioavailability of calcium and magnesium in dietary supplements and food additives
US20040106678A1 (en) * 2002-09-17 2004-06-03 Dobbins Thomas A Compositions for the parenteral administration of calcium and magnesium
JP2004201675A (ja) * 2002-12-10 2004-07-22 Arita Junichi 糖尿病予防効果を有する亜鉛高含有食品
CN1234371C (zh) * 2003-01-28 2006-01-04 马驷 纳米铜粉作为制备预防治疗骨质疏松、骨折药物的应用
US8840941B2 (en) * 2003-04-28 2014-09-23 Rifat Parvez Method for infusing calcium phosphate in water, juices and water beverages
US20040213873A1 (en) * 2003-04-28 2004-10-28 Rifat Parvez Mineral waters containing dissolved calcium, phosphorus and zinc
US20060246200A1 (en) * 2003-04-28 2006-11-02 Rifat Parvez Hydroxyapatite in aqueous solution for bone health
US7323201B2 (en) * 2004-06-08 2008-01-29 Tate & Lyle Ingredients Americas, Inc. Highly soluble form of tricalcium citrate, and methods of its making and use
US7901710B2 (en) 2005-08-04 2011-03-08 Vertical Pharmaceuticals, Inc. Nutritional supplement for use under physiologically stressful conditions
US8263137B2 (en) 2005-08-04 2012-09-11 Vertical Pharmaceuticals, Inc. Nutritional supplement for women
US8202546B2 (en) 2005-08-04 2012-06-19 Vertical Pharmaceuticals, Inc. Nutritional supplement for use under physiologically stressful conditions
US7998500B2 (en) 2005-08-04 2011-08-16 Vertical Pharmaceuticals, Inc. Nutritional supplement for women
WO2007049757A1 (ja) 2005-10-27 2007-05-03 Sunstar Inc. ラクトフェリンを含んだリポソームを含有する破骨細胞増加抑制剤、経口組成物及び骨疾患の予防又は治療剤
US20100143573A1 (en) * 2006-06-09 2010-06-10 John Godber Mineral fortification substance for clear beverages
DE102006050931A1 (de) * 2006-10-28 2008-04-30 Alzchem Trostberg Gmbh Feste oder wässrige alkalische Zubereitung auf Basis einer Kreatin-Komponente, Verfahren zu deren Herstellung und ihre Verwendung
US20090162490A1 (en) * 2007-12-20 2009-06-25 Tropicana Products, Inc. Calcium-fortified beverages and method of making thereof
EP2545788A1 (de) * 2011-07-13 2013-01-16 Martin Hulliger Diätisches Mehrkomponentensystem
AU2014204104B2 (en) * 2013-01-04 2017-02-16 Board Of Regents, The University Of Texas System Compositions comprising citrate and applications thereof
DK178709B1 (en) * 2015-06-17 2016-11-28 Dantrace APPLICATION OF ZINC AND COPPER GLUCONATES IN THE TREATMENT OF DIGITAL DERMATITIS
JP7166636B2 (ja) * 2016-07-15 2022-11-08 エイチツー ウォーター テクノロジーズ リミテッド 水素豊富水を生成するための組成物及び他の製品
KR101914624B1 (ko) 2017-01-11 2018-11-02 엘지전자 주식회사 자율주행시스템의 사고 예방을 위한 프로세서 및 동작 방법
CN115671384B (zh) * 2021-07-23 2024-06-18 中国科学院深圳先进技术研究院 一种骨修复支架及其制备方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3992555A (en) * 1973-05-07 1976-11-16 Vitamins, Inc. Supplemented food product and process for preparing same
US3949098A (en) * 1974-06-05 1976-04-06 Nabisco, Inc. Nutritious orange drink concentrate, process and drink resultant therefrom
US3950547A (en) * 1974-08-26 1976-04-13 Syntex (U.S.A.) Inc. Dietary composition and methods of preparing
US4070488A (en) * 1975-11-25 1978-01-24 Davis Rachel D Nutritive composition
US4107346A (en) * 1976-09-02 1978-08-15 Kravitz Hilard L Dietary salt compositions
DE2845570C2 (de) * 1978-10-19 1985-10-17 E.R.E. Europe Representation Establishment, Vaduz Honig enthaltende Zusammensetzung
US4351735A (en) * 1978-12-19 1982-09-28 R.G.B. Laboratories Inc. Mineral enrichment composition and method of preparing same
US4214996A (en) * 1978-12-19 1980-07-29 R.G.B. Laboratories, Inc. Mineral enrichment composition and method of preparing same
US4419369A (en) * 1980-09-22 1983-12-06 Baylor College Of Medicine Protein mineral dietary module
US4497800A (en) * 1982-07-06 1985-02-05 Mead Johnson & Company Stable liquid diet composition

Also Published As

Publication number Publication date
ATE123223T1 (de) 1995-06-15
EP0542912B1 (en) 1995-05-31
AU8503591A (en) 1992-03-02
HK1006149A1 (en) 1999-02-12
CA2088274C (en) 1995-06-27
EP0542912A1 (en) 1993-05-26
TW201692B (ko) 1993-03-11
JP3251287B2 (ja) 2002-01-28
KR0180207B1 (ko) 1999-03-20
JPH06500552A (ja) 1994-01-20
DE69110130T2 (de) 1995-11-02
IE912773A1 (en) 1992-02-12
MY107865A (en) 1996-06-29
DE69110130D1 (de) 1995-07-06
NZ239264A (en) 1994-04-27
US5151274A (en) 1992-09-29
MX9100556A (es) 1992-08-10
CA2088274A1 (en) 1992-02-07
IE66702B1 (en) 1996-01-24
WO1992002235A1 (en) 1992-02-20
SA92120558B1 (ar) 2004-05-01
AU662109B2 (en) 1995-08-24

Similar Documents

Publication Publication Date Title
KR930701183A (ko) 칼슘 및 미량의 무기물 보충제
US8557299B2 (en) Dietary supplement containing alkaline electrolyte butters
NO933992D0 (no) Kombinert kalsium og vitamin d supplementer
NO934282L (no) Kalsium, spormetall, vitamin D og medisinterapikombinasjoner
CA2158811A1 (en) Calcium dietary supplement
KR930000114A (ko) 지방산을 이용한 치료
NZ195881A (en) Pharmaceutical compositions containing cobalt compounds
KR890003390A (ko) 골다공증 및 관련된 장해의 치료방법
Spencer et al. Studies of fluoride metabolism in man: a review and report of original data
KR890003392A (ko) 영양 보강물
CN103652939A (zh) 多种维生素c胶囊
Newnham Discovering the cure for arthritis
Gillie Endemic goiter
CN1194711C (zh) 一种防治营养性缺铁性贫血的速溶颗粒
WHITFORD Fluorides: mechanisms of action, efficacy, and safety
RU93058335A (ru) Добавки, содержащие кальций и витамин д, напиток
RU2083123C1 (ru) Биологически активный пищевой комплекс
Morrison et al. Trace elements in human nutrition
DE102010053748B4 (de) Pharmazeutische Zusammensetzung zur Behandlung von Übergewicht
DE4212122C2 (de) Diätetisches energiearmes Lebensmittel zur Unterstützung ärztlicher und nicht-ärztlicher Maßnahmen gegen Osteoporose
Ammann et al. Effects of intermittent cyclical versus continuous treatment with the bisphosphonate tiludronate on bone mineral density sequentially evaluated by dual energy X-ray absorptiometry in ovariectomized rats
CN1099974A (zh) 生物保健食品“纯蛇粉”
BAVETTA Nutrition and Oral health
Kobayashi et al. Vitamin D supplementation is essential for normal bone formation and strength
Cook Spirit of the Berry Speaks to us Still

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20101026

Year of fee payment: 13

LAPS Lapse due to unpaid annual fee